3rd Nov 2009 07:00
Deltex Medical Group plc
Directors' Shareholdings
3 November 2009
Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that following the approval at General Meeting of resolutions to place an additional 22,222,222 ordinary shares of 1p each ("New Ordinary Shares") on the 30 October 2009, the directors beneficial interests are as follows:
|
Name of Director |
Number of New Ordinary Shares issued |
Holding of shares following issue of New Ordinary Shares |
% of enlarged issued share capital |
|
Nigel Keen |
1,066,666 |
5,189,638 |
4.17 |
|
Dr Edwin Snape(1) |
- |
4,072,921 |
3.27 |
|
Sir Duncan Nichol |
- |
369,691 |
0.30 |
|
Julian Cazalet |
1,066,666 |
3,206,410 |
2.57 |
|
Ewan Phillips |
158,616 |
1,159,773 |
0.93 |
(1) Includes shares held as a principal of Nexus Medical Partners II, L.P.
For further information, please contact:-
Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman Ewan Phillips, Chief Executive Paul Mitchell Finance Director
Nominated Adviser and Broker 0207 398 1600
Arden Partners plc
Christopher Hardie
Matthew Armitt
Kreab Gavin Anderson 0207 554 1400
Deborah Walter
Robert Speed
Related Shares:
Deltex Medical